Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Podcasts

Dr Bill Nelson talks to Dr Catherine Handy Marshall about the broader range or treatments available for advanced prostate cancer at the Johns Hopkins Kimmel Cancer Center that are leading to better outcomes, fewer side-effects and longer survival.

Dr Bill Nelson and Dr Sam Denmeade discuss the growing array of treatments for patients with prostate cancer available at the Johns Hopkins Kimmel Cancer Center.

Dr Bill Nelson talks to Dr John Gross, a surgical pathologist, about the diagnosis of sarcomas, tumors most commonly found in bones and soft tissue. Dr Gross recently published a paper in Modern Pathology on his team's discovery of a new type of soft tissue tumor. Read more about that here.

Dr Bill Nelson and Dr Michael Pishvaian discuss the targeting of KRAS mutations in pancreatic cancer to develop new treatment options for a disease that has been historically difficult to care for.

Dr Bill Nelson and Dr Cynthia Sears discuss the role of the microbiome on our overall health, how it impacts cancer risk and the crucial role of federal research funding in understanding these organisms.

Dr Bill Nelson and Dr Nilo Azad discuss the decades-long research effort to develop treatments targeting KRAS mutations and the importance of federal funding in bringing those treatments to patients.

Dr Bill Nelson and Dr Michael Carducci discuss using Prostate-Specific Membrane Antigen (PSMA) targeted therapies to detect and treat prostate cancer.

Dr Akila Viswanathan speaks with Dr Sophia Kamran from Harvard Medical School and Dr Constantinos Zamboglou from the German Oncology Center about the latest edition of Seminars in Radiation Oncology focusing on new treatments for advanced prostate cancer.

Dr Bill Nelson talks to Dr Elizabeth Platz about her research studying the causes of cancer over time in large groups and using data to assess future risk.

Dr Bill Nelson and Dr Bert Vogelstein discuss the development of tools for the early detection of cancers, which will lead to better treatments with fewer long-term consequences for patients.